𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sonographic measurement of the thickness of subcutaneous tissues in nonalcoholic fatty liver disease versus other chronic liver diseases

✍ Scribed by Thomas R. Riley; Michael A. Bruno


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
103 KB
Volume
33
Category
Article
ISSN
0091-2751

No coin nor oath required. For personal study only.

✦ Synopsis


Purpose:

To measure an average subcutaneous tissue thickness in nonalcoholic fatty liver disease (nafld) and other liver diseases using bedside sonography and make comparisons of thickness between groups. the study also addressed whether a cut-off subcutaneous tissue thickness exists below which nafld is unlikely.

Methods:

Sonograph was performed on 113 consecutive patients with chronic liver disease. diagnosis was derived from serological data combined with liver biopsy in all cases. distance was measured between the skin and the liver surface and was labeled the subcutaneous tissue thickness.

Results:

Of the 113 patients, 16 were diagnosed with nafld, 56 were diagnosed with chronic hepatitis c, 17 were diagnosed with autoimmune liver disease, and 24 had miscellaneous diagnoses (hepatitis b, hemochromatosis, granulomatous hepatitis, and cryptogenic hepatitis). the subcutaneous tissue thickness was 25.6 mm +/- 5.6 mm in nafld versus 19.5 mm +/- 5.2 in the non-nafld patients (p < 0.001). the subcutaneous tissue thickness of the hcv group was 20.2 mm +/- 4.8, and although it was not different than all other patients, it was different from the nafld patients (p < 0.01). fifteen out of sixteen of the nafld patients had a greater than average subcutaneous tissue thickness (20 mm).

Conclusions:

A sonographically measured subcutaneous tissue thickness of less than 20 mm makes the diagnosis of nafld unlikely.


πŸ“œ SIMILAR VOLUMES


Diagnosis of fibrosis and cirrhosis usin
✍ Vincent Wai-Sun Wong; Julien Vergniol; Grace Lai-Hung Wong; Juliette Foucher; He πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 263 KB πŸ‘ 1 views

Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in affluent countries. Accurate noninvasive tests for liver injury are urgently needed. The aim of this study was to evaluate the accuracy of transient elastography for the diagnosis of fibrosis and cirrhosis in patien

Progress in understanding the pathogenes
✍ Richard H. Moseley πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 159 KB πŸ‘ 1 views

The pathogenesis of nonalcoholic steatohepatitis (NASH) is poorly defined. Feeding mice a diet deficient in methionine and choline (MCD diet) induces experimental NASH. Osteopontin (OPN) is a Th1 cytokine that plays an important role in several fibroinflammatory diseases. We examined the role of OPN

Racial and ethnic distribution of nonalc
✍ Shiobhan R. Weston; Wendy Leyden; Rose Murphy; Nathan M. Bass; Beth P. Bell; M. πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 188 KB

We performed a cross-sectional study of newly diagnosed cases of nonalcoholic fatty liver disease (NAFLD) identified between December 1998 and December 2000 in the Chronic Liver Disease Surveillance Study. We compared the demographic and clinical features of NAFLD in a racially diverse representativ

Evolution of inflammation in nonalcoholi
✍ Herbert Tilg; Alexander R. Moschen πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 376 KB πŸ‘ 1 views

Whereas in most cases a fatty liver remains free of inflammation, 10%-20% of patients who have fatty liver develop inflammation and fibrosis (nonalcoholic steatohepatitis [NASH]). Inflammation may precede steatosis in certain instances. Therefore, NASH could reflect a disease where inflammation is f

Changing shape of disease: Nonalcoholic
✍ Christopher E. McGowan; Patricia Jones; Millie D. Long; A. Sidney Barritt IV πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

Background: With improvements in therapy for inflammatory bowel disease (IBD) and changes in the prevalence of obesity, the phenotype of Crohn's disease (CD) is changing. These changes may herald an increase in the incidence of nonalcoholic fatty liver disease (NAFLD) in this population. Methods: O